Home/Filings/4/0001104659-23-055649
4//SEC Filing

Poll Claire 4

Accession 0001104659-23-055649

CIK 0001657312other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 7:49 PM ET

Size

6.4 KB

Accession

0001104659-23-055649

Insider Transaction Report

Form 4
Period: 2023-05-01
Poll Claire
General Counsel
Transactions
  • Sale

    Ordinary Shares

    2023-05-01$2.58/sh80,376$207,0411,979,063 total
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    774,256
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the sale price of the ADSs divided by eight (8).
  • [F4]Consists of (i) 1,641,672 Ordinary Shares underlying RSUs (which are represented by 205,209 ADSs); (ii) 337,384 Ordinary Shares underlying 42,173 ADSs and (iii) 7 Ordinary Shares.
  • [F5]Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.

Issuer

Verona Pharma plc

CIK 0001657312

Entity typeother

Related Parties

1
  • filerCIK 0001836820

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 7:49 PM ET
Size
6.4 KB